Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China

Jing-bo Wang; Xiang-jun Liu; Wei-jie Zhang

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China

【24h】

Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China

机译：None

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共1页
作者
Jing-bo Wang; Xiang-jun Liu; Wei-jie Zhang;
展开▼
作者单位

Hematology China Aerospace Central Hospital;

Beijing BFR Gene Diagnostics;

Hematology China Aerospace Central Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
专利

1. Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China [J] . Jing-bo Wang, Xiang-jun Liu, Wei-jie Zhang Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
2. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation. [J] . Kroger N, Binder T, Zabelina T, Transplantation: Official Journal of the Transplantation Society . 2006,第8期

机译：供体激活的杀伤性免疫球蛋白样受体（KIR）基因数量少，但KIR-配体错配率不高，可防止体内T细胞枯竭无关干细胞移植后复发，并改善白血病患者的无病生存期。
3. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [J] . Dalila Salvatore, Myriam Labopin, Annalisa Ruggeri, Haematologica . 2018,第8期

机译：初次完全缓解并伴有中等或高风险细胞遗传学的急性髓细胞性白血病患者中未经操纵的单倍体或相配的同胞供体进行造血干细胞移植的结果：一项来自欧洲血液和骨髓移植学会急性白血病工作组的研究
4. Computationally derived cytological image markers for predicting risk of relapse in acute myeloid leukemia patients following bone marrow transplantation [C] . Sara ArabYarmohammadi, Zelin Zhang, Patrick Leo, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [O] . Dalila Salvatore, Myriam Labopin, Annalisa Ruggeri, 2018

机译：初次完全缓解并伴有中等或高风险细胞遗传学的急性髓细胞性白血病患者中未经操纵的单倍体或相配的同胞供体进行造血干细胞移植的结果：一项来自欧洲血液和骨髓移植学会急性白血病工作组的研究
7. Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China [O] . Jing-bo Wang, Xiang-jun Liu, Wei-jie Zhang 2018

机译：供体KIR激活基因和患者KIR配体状态调节白血病复发和白血病在杂志造血干细胞移植后的白血病复发和白血病免费生存，以高风险AML和中国的所有患者为主。

相关主题

Donor KIR-Activating Genes and Patient KIR Ligand Status Modulate Leukemia Relapse and Leukemia Free Survival after Haploidentical Hematopoietic Stem Cell Transplantation in a Cohort Dominated by High Risk AML and ALL Patients in China

著录项

相似文献

相关主题

期刊订阅